MedPath

Acupuncture in the Treatment of Fatigue in Parkinson's Disease

Not Applicable
Completed
Conditions
Parkinson Disease
Fatigue
Interventions
Device: Acupuncture
Registration Number
NCT02587754
Lead Sponsor
Tan Tock Seng Hospital
Brief Summary

This study evaluates the efficacy of acupuncture in the treatment of fatigue in participants with Parkinson's Disease. Half of participants will receive real acupuncture while the half will receive placebo acupuncture.

Detailed Description

This will be a single centre, single blinded 2-group randomized controlled study, with participants receiving either verum acupuncture or placebo acupuncture.

A retractable non-invasive placebo needle will be used in the placebo arm. Both the real and placebo needles have a fine needle body and copy handle and look exactly the same. However, the placebo needle has a retractable shaft and blunt tip. When pressed onto the skin, it telescopes into the handle and the blunt tip stays on the skin instead of penetrating it. The plastic tube with adhesive foot-plate is placed on the skin to hold it in place. The real needle, on the other hand, has a normal sharp tip which allows it to pierce the skin.

The following acupoints will be needled: Stomach 36 (bilateral), Spleen 6 (bilateral), Kidney 3 (bilateral), Large Intestine 4 (bilateral), Pericardium 6 (bilateral), and Conception Vessel 6. These points were chosen based on Traditional Chinese Medicine theory (which attributed fatigue to deficiencies of spleen, kidney and qi).

Each acupuncture session will be based on a strict protocol, and conversation between acupuncturists and participants will be kept to a minimum.

Participants will be assessed at 3 intervals:

1. Week 0 (baseline)

2. Week 5 (completion of intervention)

3. Week 9 (4 weeks after completion of intervention

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Diagnosis of PD based on criteria developed by Gelb et al which is adopted by the National Institute of Neurological Disorders and Stroke, US National Institute of Health.
  2. Age 21-85 years old
  3. Presence of persistent fatigue of a moderate level for at least 4 weeks' duration. Moderate fatigue is defined as a score of β‰₯10 on the general fatigue domain of the Multidimensional Fatigue Inventory.
  4. No acupuncture treatment in the past 6 months.
Exclusion Criteria
  1. Significant cognitive, language or psychiatric illnesses which prevents the subject from understanding instructions and participating in the study.
  2. Needle phobia
  3. Comorbidity with a bleeding disorder
  4. Known anemia with hemoglobin level less than 10g/dl.
  5. Known congestive cardiac failure and/or end stage renal disease
  6. Female subjects of childbearing age
  7. Presence of symptomatic postural hypotension

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Verum acupunctureAcupuncture10 sessions of verum acupuncture
Placebo acupunctureAcupuncture10 sessions of placebo acupuncture via use of placebo acupuncture needles
Primary Outcome Measures
NameTimeMethod
General Fatigue score of the Multidimensional Fatigue InventoryGeneral Fatigue score of the Multidimensional Fatigue Inventory at week 5

Measure of fatigue

Secondary Outcome Measures
NameTimeMethod
General Fatigue score of the Multidimensional Fatigue InventoryGeneral Fatigue score of the Multidimensional Fatigue Inventory at week 9

Measure of fatigue

Unified Parkinson's Disease Rating Scale (UPDRS)UPDRS score at week 9

Measure of severity of Parkinson's Disease

Parkinson's Disease Questionnaire-39 (PD 39).PD 39 score at week 9

Measure of quality of life

Geriatric Depression Scale (GDS)GDS score at week 9

Measure of depression

Trial Locations

Locations (1)

Tan Tock Seng Hospital

πŸ‡ΈπŸ‡¬

Singapore, Singapore

Β© Copyright 2025. All Rights Reserved by MedPath